Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10017941 | Annals of Emergency Medicine | 2005 | 5 Pages |
Abstract
Symptomatic intracerebral hemorrhage risk is the factor most likely to preclude rt-PA use by emergency physicians. Of the 40% of physicians who would not use rt-PA, about two thirds reported this was due to symptomatic intracerebral hemorrhage risk, and about a quarter of physicians cited the relative lack of benefit. Treatment trials that aim to reduce symptomatic intracerebral hemorrhage risk to 2% to 3% are likely to stimulate the interest of emergency physicians in the use of thrombolytics for acute ischemic stroke.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Devin L. MD, William G. MD, Lynda D. PhD, Michael E. PhD, Lewis B. MD,